I am a Postdoctoral Researcher in Drug Discovery Technologies Group at IBM Thomas J. Watson Research Center. Before IBM, I was a Scientist, Computational Biology at NuMedii, Inc. I also did research at National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA) for four years.
My research interest include bioinformatics, drug safety evaluation, drug repositioning and precision medicine. I leverage the information of in silico chemical-protein interactome (CPI), gene expression data and post-market survilience data and combine it with approaches such as machine learning and statistical analysis for translational bioinformatics, drug discovery and precision medicine applications.